Clinical Trial Update: Evolocumab In Advanced Chronic Kidney Disease Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial of evolocumab in advanced chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypercholesterolemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: NYU Langone Health | Conditions: Chronic Kidney Diseases, High Cholesterol | Phase 4 | Status: WITHDRAWN